A clinical correlation of anti-DNA-AGE autoantibodies in type 2 diabetes mellitus with disease duration

Cellular Immunology

Volumn 293, Issue 2, 2015, Pages 74-79

  Ashraf, Jalaluddin M ^a,b   Arfat, Mir Yasir ^a   Arif, Zarina ^a   Ahmad, Jamal ^a   Moinuddin, ^a   Alam, Khursheed ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b Yeungnam University   (South Korea)

Author keywords

Autoantibodies; CEdG; DNA; Glucose; Glycation; Type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AGAROSE; AUTOANTIBODY; DNA BASE; GLUCOSE; IMMUNOGLOBULIN G; PROTEIN A; BIOLOGICAL MARKER; DNA;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; GEL ELECTROPHORESIS; GEL MOBILITY SHIFT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MELTING POINT; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL DENSITY; PRIORITY JOURNAL; AGED; ATHEROSCLEROSIS; BLOOD; CONFORMATION; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; IMMUNOLOGY; ULTRASTRUCTURE; ULTRAVIOLET SPECTROPHOTOMETRY;

MAMMALIA;

ADULT; AGED; ATHEROSCLEROSIS; AUTOANTIBODIES; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; NUCLEIC ACID CONFORMATION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84920656072     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.12.007     Document Type: Article

References (47)

1. P.H. Bennett, Definition, diagnosis and classification of diabetes mellitus and impaired glucose tolerance, in: C.R. Kahn, G.C. Weir (Eds.), Joslins Diabetes Mellitus, Lea & Febiger, Philadelphia, 1994, pp. 193-200.
2. Uribarri J., Cai W., Peppa M., Goodman S., Ferucci L., Striker G., Vlassara H. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress and aging. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62:427-433.
3. Arfat M.Y., Ashraf J.M., Arif Z., Moinuddin, Alam K. Fine characterization of glycosylated human IgG by biochemical and biophysical methods. Int. J. Biol. Macromol. 2014, 69:408-415.
4. Alam S., Arif Z., Alam K. Glycated-H2A histone is better bound by serum anti-DNA autoantibodies in SLE patients: glycated-histones as likely trigger for SLE?. Autoimmunity 2014, 10.3109/08916934.2014.941059.
5. Seneviratne C., Dombi G.W., Liu W., Dain J.A. The in vitro glycation of human serum albumin in the presence of Zn(II). J. Inorg. Biochem. 2011, 105:1548-1554.
6. Mir A.R., Moinuddin, Alam K., Ali A. Methylglyoxal mediated conformational changes in histone H2A-generation of carboxyethylated advanced glycation end products. Int. J. Biol. Macromol. 2014, 69:260-266.
7. Uribarri J., Tuttle K.R. Advanced glycation end products and nephrotoxicity of high-protein diets. Clin. J. Am. Soci. Nephrol. 2006, 5:1293-1299.
8. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19:257-267.
9. Park L., Raman K.G., Lee K.J., Lu Y., Ferran L.J., Chow W.S., Stern D., Schmidt A.M. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 1998, 4:1025-1031.
10. Singh R., Barden A., Mori T., Beilin L. Advanced glycation end-products: a review. Diabetologia 2001, 44:129-146.
11. Yokokawa N., Aizawa T., Ishihara M., Koizumi Y., Yanangisawa K., Yamada T. Presence of anti-DNA antibodies in diabetes mellitus: its relation to the duration of diabetes and diabetic complications. Metabolism 1989, 38:891-894.
12. Ahmad S., Moinuddin, Habib S., Shahab U., Alam K., Alam A. Autoimmune response to AGE modified human DNA: implications in type 1 diabetes mellitus. J. Clin. Trans. Endocri. 2014, 1:66-72.
13. Leslie D., Lipsky P., Notkins A.L. Autoantibodies as predictors of disease. J. Clin. Invest. 2001, 108:1417-1422.
14. Makino H., Shikata K., Hironaka K., Kushiro M., Yamasaki Y., Sugimoto H., Ota Z., Araki N., Horiuchi S. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int. 1995, 48:517-526.
15. Kume S., Takeya M., Mori T., Araki N., Suzuki H., Horiuchi S., Kodama T., Miyauchi Y., Takahashi K. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 1995, 147:654-667.
16. Khan Z.A., Chakrabarti S. Cellular signalling and potential new treatment targets in diabetic retinopathy. Exp. Diabetes Res. 2007, 3186-3187.
17. Shibayama R., Araki N., Nagai R., Horiuchi S. Autoantibody against N2-(carboxymethyl) lysine: an advanced glycation end product of the Millard reaction. Diabetes 1999, 48:1842-1849.
18. Stopper H., Schinzel R., Sebekova K., Heidland A. Genotoxicity of advanced glycation end products in mammalian cells. Cancer Lett. 2003, 190:51-56.
19. Ahmad S., Moinuddin K., Dixit U., Shahab K., Alam A. Ali, Genotoxicity and immunogenicity of DNA-advanced glycation end products formed by methylglyoxal and lysine in the presence of Cu2+. Biochem. Biophys. Res. Commun. 2011, 407:568-574.
20. Dutta U., Cohenford M.A., Dain J.A. The effect of nonenzymatic glycation on the stability and conformation of two deoxyoligonucleotide duplexes: a spectroscopic analysis by circular dichroism. Anal. Biochem. 2007, 360:235-243.
21. Dutta U., Cohenford M.A., Guha M., Dain J.A. In vitro nonenzymatic glycation of DNA nucleobases: an evaluation of advanced glycation end products under alkaline pH. Anal. Bioanal. Chem. 2006, 386:1633-1640.
22. Ahmad J., Gupta A., Alam K., Farooqui K.J. Detection of autoantibodies against glycosylated-DNA in diabetic subjects: its possible correlation with HbA1C. Dis. Mark 2011, 30:235-243.
23. Shahab U., Tabrez S., Khan M.S., Saeed M., Ahmad K., Srivastava A.K., Ahmad S. Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe3+: its potential role in prompt recognition of diabetes mellitus auto-antibodies. Chem. Biol. Interact. 2014, 219:229-232.
24. Frischmann M., Bidmon C., Angerer J., Pischetsrieder M. Identification of DNA adducts of methylglyoxal. Chem. Res. Toxicol. 2005, 18:1586-1592.
25. Schneider M., Thoss G., Hubner-Parajsz C., Kientsch-Engel R., Stahl P., Pischetsrieder M. Determination of glycated nucleobases in human urine by a newmonoclonal antibody specific for N2-carboxyethyl-2-deoxyguanosine. Chem. Res. Toxicol. 2004, 17:1385-1390.
26. Li H., Nakamura S., Miyazaki S., Morita T., Suzuki M., Pischetsrieder M., Niwa T. N2-carboxyethyl-2-deoxyguanosine, a DNA glycation marker, in kidneys and aortas of diabetic and uremic patients. Kidney Int. 2006, 69:388-392.
27. Ali R., DerSimonian H., Stollar B.D. Binding of monoclonal anti-native DNA autoantibodies to DNA of varying size and conformation. Mol. Immunol. 1985, 22:1415-1422.
28. Goding J.W. Use of staphylococcal protein A as an immunological reagent. J. Immunol. Methods 1978, 20:241-253.
29. Ali R., Alam K. Evaluation of antibodies against oxygen free radical-modified DNA by ELISA. Methods Mol. Biol. 2002, 186:171-181.
30. Alam K., Moinuddin, Jabeen S. Immunogenicity of mitochondrial DNA modified by hydroxyl radical. Cell. Immunol. 2007, 247:12-17.
31. Ashraf J.M., Arif B., Dixit K., Moinuddin, Alam K. Physicochemical analysis of structural changes in DNA modified with glucose. Int. J. Biol. Macromol. 2012, 51:604-611.
32. Thornalley P.J. The enzymatic defence against glycation in health, disease and therapeutics: a symposium to examine the concept. Biochem. Soc. Trans. 2003, 31:1341-1342.
33. F. Akhter, S.M. Khan, U. Shahab, Moinuddin, S. Ahmad, Bio-physical characterization of ribose induced glycation: A mechanistic study on DNA perturbations, Int. J. Bio.l Macromol. 58 (2013) 206-210.
34. Mustafa I., Ahmad S., Dixit K., Moinuddin, Ahmad J., Ali A. Glycated human DNA is a preferred antigen for anti-DNA antibodies in diabetic patients. Diabetes Res. Clin. Pract. 2012, 95:98-104.
35. Thornalley P.J. Clinical significance of glycation. Clin. Lab. 1999, 45:263-273.
36. Lorenzi M., Montisano D.F., Toledo S., Wong H.C. Increased single strand breaks in DNA of lymphocytes from diabetic subjects. Clin. Invest. 1987, 79:653-656.
37. Thornally P.J. Pharmacology of methylation: formation modification of proteins and nucleic acids and enzymatic detoxification-a role in pathogenesis and antiprolifirative chemotherapy. Gen. Pharmacol. 1997, 27:565-573.
38. W. Seidel, M. Pischetsrieder, DNA-glycation leads to depurination by the loss of N2-carboxyethylguanine in vitro, Cell. Mol. Biol. (Noisy-le-grand) 44 (1998) 1165-1170.
39. Pischetsrieder M., Seidel W., Munch G., Schinzel R. N(2)-(1-carboxyethyl) deoxyguanosine, a nonenzymatic glycation adduct of DNA, induces single-strand breaks and increases mutation frequencies. Biochem. Biophys. Res. Commun. 1999, 264:544-549.
40. Turk Z., Ljubic S., Turk N., Benko B. Detection of autoantibodies against advanced glycation end products and immune complexes in serum of patients with diabetes mellitus. Clin. Chim. Acta 2001, 303:105-115.
41. Pihoker C., Gilliam L.K., Hampe C.S., Lernmark A. Autoantibodies in diabetes. Diabetes 2005, 54:52-61.
42. D. Casiglia, A. Accardo-Palumbo, G. Triolo, et al. Soluble ICAM-1 in type I diabetes mellitus, Association with anti-endothelial cell antibodies, Proc. VII Intern. Symp. Bio. Vas. Cell San Diego Calif (1992) 37.
43. Triolo G., Accardo-Palumbo A., Giardina E., Davi G., Triolo G. Anti platelet property of anti-single-stranded DNA antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res. 1994, 26:79-87.
44. Shahab U., Moinuddin, Ahmad S., Dixit K., Abidi S.M., Alam K., Ali A. Acquired immunogenicity of human DNA damaged by N-hydroxy-N-acetyl-4-aminobiphenyl. IUBMB Life 2012, 64:340-345.
45. B. Arif, J.M. Ashraf, Moinuddin, J. Ahmad, Z. Arif, K. Alam, Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus, Arch. Biochem. Biophys. 522 (2012) 17-25.
46. Ahmad S., Moinuddin, Ali A. Immunological studies on glycated human IgG. Life Sciences 2012, 90:980-987.
47. Ahmad M.I., Ahmad S., Moinuddin Preferential recognition of methylglyoxal modified calf thymus DNA by circulating antibodies in cancer patients. Indian J. Biochem. Biophys. 2011, 48:290-296.